AMF Tjanstepension AB Increases Stock Position in Stryker Corporation $SYK

AMF Tjanstepension AB increased its position in Stryker Corporation (NYSE:SYK) by 7.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 187,059 shares of the medical technology company’s stock after purchasing an additional 13,524 shares during the quarter. AMF Tjanstepension AB’s holdings in Stryker were worth $65,746,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. VanderPol Investments L.L.C. raised its holdings in Stryker by 1.4% in the fourth quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company’s stock valued at $732,000 after acquiring an additional 28 shares in the last quarter. Lantz Financial LLC raised its holdings in Stryker by 5.0% in the third quarter. Lantz Financial LLC now owns 608 shares of the medical technology company’s stock valued at $225,000 after acquiring an additional 29 shares in the last quarter. Stonebridge Capital Advisors LLC raised its holdings in Stryker by 0.4% in the third quarter. Stonebridge Capital Advisors LLC now owns 7,198 shares of the medical technology company’s stock valued at $2,661,000 after acquiring an additional 29 shares in the last quarter. Tcfg Wealth Management LLC raised its holdings in Stryker by 2.7% in the third quarter. Tcfg Wealth Management LLC now owns 1,091 shares of the medical technology company’s stock valued at $403,000 after acquiring an additional 29 shares in the last quarter. Finally, Mechanics Financial Corp raised its holdings in Stryker by 1.2% in the fourth quarter. Mechanics Financial Corp now owns 2,458 shares of the medical technology company’s stock valued at $864,000 after acquiring an additional 30 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently issued reports on SYK shares. Evercore set a $355.00 price target on shares of Stryker in a report on Friday, May 1st. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a report on Saturday. Leerink Partners initiated coverage on shares of Stryker in a report on Monday, April 13th. They set an “outperform” rating and a $410.00 target price on the stock. William Blair reissued an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Finally, TD Cowen cut shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective on the stock. in a report on Monday, January 26th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Stock Performance

Shares of SYK opened at $312.99 on Tuesday. The firm has a 50-day moving average price of $328.54 and a 200 day moving average price of $351.06. The firm has a market capitalization of $119.99 billion, a PE ratio of 36.23, a P/E/G ratio of 1.93 and a beta of 0.80. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is currently 40.74%.

Insider Transactions at Stryker

In related news, VP M Kathryn Fink sold 5,220 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the transaction, the vice president owned 13,137 shares in the company, valued at $3,728,937.45. This represents a 28.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 4.60% of the stock is owned by corporate insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.